FTRE
Price
$8.68
Change
-$0.24 (-2.69%)
Updated
Sep 26 closing price
Capitalization
788.14M
49 days until earnings call
HRGN
Price
$1.84
Change
-$0.15 (-7.54%)
Updated
Sep 25 closing price
Capitalization
31.59M
42 days until earnings call
Interact to see
Advertisement

FTRE vs HRGN

Header iconFTRE vs HRGN Comparison
Open Charts FTRE vs HRGNBanner chart's image
Fortrea Holdings
Price$8.68
Change-$0.24 (-2.69%)
Volume$1.05M
Capitalization788.14M
Harvard Apparatus Regenerative Technology
Price$1.84
Change-$0.15 (-7.54%)
Volume$1.86K
Capitalization31.59M
FTRE vs HRGN Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. HRGN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a StrongBuy and HRGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (FTRE: $8.68 vs. HRGN: $1.84)
Brand notoriety: FTRE and HRGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 56% vs. HRGN: 108%
Market capitalization -- FTRE: $788.14M vs. HRGN: $31.59M
FTRE [@Biotechnology] is valued at $788.14M. HRGN’s [@Biotechnology] market capitalization is $31.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileHRGN’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • HRGN’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than HRGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while HRGN’s TA Score has 6 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 4 bearish.
  • HRGN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HRGN is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -14.31% price change this week, while HRGN (@Biotechnology) price change was -5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.96%. For the same industry, the average monthly price growth was +9.24%, and the average quarterly price growth was +51.43%.

Reported Earning Dates

FTRE is expected to report earnings on Nov 17, 2025.

HRGN is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($788M) has a higher market cap than HRGN($31.6M). HRGN YTD gains are higher at: -38.255 vs. FTRE (-53.458). HRGN has higher annual earnings (EBITDA): -6.52M vs. FTRE (-858.4M). FTRE has more cash in the bank: 81.2M vs. HRGN (786K). HRGN has less debt than FTRE: HRGN (249K) vs FTRE (1.24B). FTRE has higher revenues than HRGN: FTRE (2.73B) vs HRGN (679K).
FTREHRGNFTRE / HRGN
Capitalization788M31.6M2,494%
EBITDA-858.4M-6.52M13,172%
Gain YTD-53.458-38.255140%
P/E RatioN/AN/A-
Revenue2.73B679K402,504%
Total Cash81.2M786K10,331%
Total Debt1.24B249K498,394%
FUNDAMENTALS RATINGS
HRGN: Fundamental Ratings
HRGN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREHRGN
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 8 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STBMF0.320.03
+10.94%
St. Barbara Ltd.
HUSQF5.59N/A
N/A
Husqvarna AB
DMFG55.00N/A
N/A
Decker Manufacturing Corp.
SUVPF221.24N/A
N/A
Sartorius AG
BACRP215.00N/A
N/A
Bank of America Corp.

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-2.69%
TECH - FTRE
40%
Loosely correlated
+2.71%
JAZZ - FTRE
40%
Loosely correlated
-0.63%
SYRE - FTRE
40%
Loosely correlated
+4.04%
XNCR - FTRE
39%
Loosely correlated
+12.00%
TERN - FTRE
39%
Loosely correlated
+2.69%
More

HRGN and

Correlation & Price change

A.I.dvisor tells us that HRGN and FTRE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HRGN and FTRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRGN
1D Price
Change %
HRGN100%
N/A
FTRE - HRGN
6%
Poorly correlated
-2.69%
APLM - HRGN
3%
Poorly correlated
N/A
GENFF - HRGN
2%
Poorly correlated
N/A
ANL - HRGN
2%
Poorly correlated
-3.37%
CLDI - HRGN
2%
Poorly correlated
+8.28%
More